It used to be (back in the old days) that “doing” telemedicine (TM) was so new and foreign to everyone that it was considered research, and thus required—at most institutions—human subjects or Internal Review Board (IRB) approval. Patients had to be consented into a study prior to engaging in any sort of telemedicine encounter.
Thankfully, for the most part, those days are gone. While some institutions may still require IRB consent, that number has decreased significantly. Of course, if you are conducting a scientific experiment using a new telemedicine device or some new procedure, that study will have to go through the usual IRB approvals and involved patients will need to be consented.
This does not mean, however, that consent is gone for “every-day,” routine teleconsultations. What is generally required now is the type of informed consent that any patient signs when receiving medical care. That consent for telemedicine, however, comes in different flavors. Some states just require the standard patient consent to be seen without any additional language about telemedicine. Some require the standard consent to have additional telemedicine language—and the exact wording varies, as does the need to initial or sign in multiple places. Some states require a separate informed consent for telemedicine (often in addition to the standard consent to be seen).
Currently, 29 states include some sort of telemedicine informed consent requirement in their statutes, administrative codes and/or Medicaid policies. You should always determine in advance what the policies and requirements are for your state. The Center for Connected Health Policy (CCHP) (http://www.cchpca.org) and the American Telemedicine Association (ATA) (http://www.americantelemed.org/home) provide overviews of current state policies.
Increasingly, practice guidelines from the ATA and other professional societies are recommending that standard consent protocols be followed as with all patients, but that for telemedicine encounters the “informed” aspect should be focused on educating the patient about the unique nature of the telemedicine encounter compared to a face-to-face visit. Patients (and providers) need to understand how telemedicine works: What type of technology is used; what types of problems to expect (e.g., lost connection) and what to do if a technology problem arises; what are the limitations with respect to privacy and security; what happens if an emergency arises during the encounter; how will the teleconsultion be followed up (with the patient, their local providers, their health records, their pharmacy, their caregivers, etc.); what are prescribing limitations; and so on.
Some basics to keep in mind, at least for an initial encounter and maybe periodically thereafter if there are additional visits, include:
It is useful to periodically check the status of your state’s current laws and Medicaid policies on informed consent for telemedicine either via the CCHP, ATA or your regional Telehealth Resource Center. Your state may have specific policies on what provider types may obtain the informed consent (especially in the case of behavioral health) and what items the informed consent must include.
And even if your state doesn’t have specific rules on informed consent for telemedicine, keep in mind that informed consent not only informs and protects the patient, but also, according the MedPro Group, protects the provider from the risk of facing consent-based negligence claims.
Much of this is common sense, but every now and then it helps to remind everyone!
This article was co-authored by Elizabeth Krupinski and Nancy Rowe. Nancy Rowe joined the Arizona Telemedicine Program in January 2014 as the Flagstaff-based associate director for outreach after directing the telemedicine program at Northern Arizona Regional Behavioral Health Authority for more than 10 years. She is a past chair of the American Telemedicine Association Business and Finance Special Interest Group.